Latest Research And Development News

Page 55 of 82
Noxopharm has initiated its HERACLES clinical trial for SOF-SKN, marking a key milestone for its Sofra platform, while deepening partnerships and actively seeking new funding to sustain development.
Ada Torres
Ada Torres
30 July 2025
Ardea Resources reports significant progress on its Kalgoorlie Nickel Project, completing key drilling and metallurgical work while securing $4.6 million in strategic funding from Sumitomo Metal Mining. The company remains well-funded as its joint venture partners advance the Definitive Feasibility Study.
Maxwell Dee
Maxwell Dee
30 July 2025
WA Kaolin Limited reports robust production growth and expanding sales, driven by new technical kaolin grades and strong forward orders for FY26.
Maxwell Dee
Maxwell Dee
30 July 2025
Immutep Limited advances its pivotal Phase III lung cancer trial and reports promising results across multiple oncology and autoimmune programs, supported by a solid cash position to fund operations through 2026.
Ada Torres
Ada Torres
30 July 2025
Spectur Limited reports a positive operating cash flow for Q4 FY25, driven by revenue growth and cost-cutting, alongside strategic investments in cloud and connectivity technology.
Sophie Babbage
Sophie Babbage
30 July 2025
Spectur Limited reported a solid quarter ending June 2025, posting positive net operating cash flow and increasing its cash reserves to over $1 million. The company maintained steady financing arrangements while managing operating costs effectively.
Sophie Babbage
Sophie Babbage
30 July 2025
OncoSil Medical has reported a record 20% quarterly increase in dose sales and secured $8.7 million in new capital, underpinning its clinical and commercial expansion in pancreatic cancer treatment.
Ada Torres
Ada Torres
29 July 2025
Biotron Limited has successfully raised $1.27 million through an entitlement issue to fund its antiviral drug development, including a promising Hepatitis B compound that cleared its initial animal safety study.
Ada Torres
Ada Torres
29 July 2025
Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program with dose escalation and FDA Fast Track status, alongside promising early results in AML trials and a successful $6.6 million capital raise.
Ada Torres
Ada Torres
29 July 2025
Radiopharm Theranostics reports significant progress in its oncology radiopharmaceutical pipeline, including FDA Fast Track designation and dose escalation approvals, supported by a solid cash runway through mid-2026.
Ada Torres
Ada Torres
29 July 2025
Iondrive Limited advances its proprietary battery recycling technology with a pilot plant design, European consortium formation, and new e-waste initiatives, supported by significant grant funding.
Maxwell Dee
Maxwell Dee
29 July 2025
Biome Australia Limited has delivered record sales revenue in Q4 FY25 alongside positive EBITDA, setting the stage for its first full-year net profit. Strategic product launches and international expansion underpin its strong growth trajectory.
Ada Torres
Ada Torres
29 July 2025